Skip Nav Destination
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial
Issue Archive
July 2 2024
In Progress
CLINICAL TRIALS AND OBSERVATIONS
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS
Clinical Trials & Observations
Jad Othman,Ho Pui Jeff Lam,Sarah Leong,Faisal Basheer,Islam Abdallah,Kathryn Fleming,Priyanka Mehta,Heba Yassin,John Laurie,Michael Austin,Paolo Gallipoli,Tom Taylor,Mike Dennis,Johnathon Elliot,Georgina Clarke,Raymond Dang,Jennifer Vidler,Pramila Krishnamurthy,Anne-Louise Latif,Pallavi Kalkur,Maryam Shahidianakbar,Victoria Campbell,Deepak Mannari,Emily Sutherland,Thishakya Wickramaratne,Angela Collins,Rui Zhao,Herng Mak,Edward Belsham,Shabnam Banerjee,Jamila Bashir,Srinivas Pillai,Richard Whitmill,Sofia Galli,Mariam Amer,Vidhya Murthy,Duncan Murray,Farooq Wandroo,Francesca Hogan,Francesca Crolla,Nicole Fowler,Anjum Khan,Jenny O’Nions,Richard Dillon
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial
Clinical Trials & Observations
Ulrich Dührsen,Andreas Bockisch,Bernd Hertenstein,Imke E. Karsten,Frank Kroschinsky,Michael Heuser,Andreas Hochhaus,Heinz-Gert Höffkes,Dirk Behringer,Gabriele Prange-Krex,Mareike Tometten,Martin Grieshammer,Götz U. Grigoleit,Oliver Schmalz,Karin Jordan,Helga Bernhard,Tobias Gaska,Aristoteles Giagounidis,Roland Schroers,Uwe M. Martens,Gerhard Held,Wolfram Klapper,Karl-Heinz Jöckel,Michael Nonnemacher,Andreas Hüttmann,on behalf of the PETAL Trial Investigators
Lymphoid Neoplasia
Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital system
Jun Y. Jiang,Chijioke Nze,Danielle Guffey,Rockbum Kim,Abiodun O. Oluyomi,Omar Rosales,Raka Bandyo,Courtney N. Miller-Chism,Mark M. Udden,Martha P. Mims,Hilary Ma,Gustavo A. Rivero,Akiva Diamond,Purnima S. Teegavarapu,Ang Li,Christopher R. Flowers
Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma
Priya Choudhry,Corynn Kasap,Bonell Patiño-Escobar,Olivia Gugliemini,Huimin Geng,Vishesh Sarin,Amrik Kang,Audrey Kishishita,Sham Rampersaud,Letitia Sarah,Yu-Hsiu T. Lin,Neha Paranjape,Poornima Ramkumar,Jonathan C. Patton,Makeba Marcoulis,Donghui Wang,Paul Phojanakong,Veronica Steri,Byron Hann,Benjamin G. Barwick,Martin Kampmann,Arun P. Wiita
MYELOID NEOPLASIA
Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level
Johann-Christoph Jann,Nanni Schmitt,Alexander Streuer,Qingyu Xu,Vladimir Riabov,Eva Altrock,Nadine Weimer,Verena Nowak,Julia Obländer,Iris Palme,Melda Göl,Marie Demmerle,Felicitas Rapp,Fabian Siegel,Laurenz Steiner,Mahmoud Ghazal,Angelika Duda,Verena Haselmann,Ali Darwich,Ahmed Jawhar,Mohamad Jawhar,Georgia Metzgeroth,Wolf-Karsten Hofmann,Daniel Nowak
RESEARCH LETTER
Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study
Amy E. DeZern,Johannes B. Goll,Travis L. Jensen,Sridhar Nonavinkere Srivatsan,Nancy K. Gillis,Gregory A. Abel,Eric Padron,H. Joachim Deeg,Tareq Al Baghdadi,Jane Jijun Liu,Rami S. Komrokji,Steven D. Gore,Wael Saber,Rafael Bejar,Matthew J. Walter,R. Coleman Lindsley,Seth Sherman,Nancy DiFronzo,Mikkael A. Sekeres
Advertisement intended for health care professionals
Advertisement intended for health care professionals